InspireMD (NASDAQ: NSPR) reported Q2 EPS of ($0.22), $0.03 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $1.74 million versus the consensus estimate of $1.74 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.